Blaise Coleman - 05 Jun 2025 Form 4 Insider Report for Ocugen, Inc. (OCGN)

Role
Director
Signature
/s/ Blaise Coleman by Shankar Musunuri, his attorney-in-fact
Issuer symbol
OCGN
Transactions as of
05 Jun 2025
Net transactions value
$0
Form type
4
Filing time
09 Jun 2025, 17:19:31 UTC
Previous filing
31 Mar 2022
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Coleman Blaise Director C/O OCUGEN, INC., 11 GREAT VALLEY PARKWAY, MALVERN /s/ Blaise Coleman by Shankar Musunuri, his attorney-in-fact 09 Jun 2025 0001689280

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCGN Option (Right to Buy) Award $0 +151,316 $0.000000 151,316 05 Jun 2025 Common Stock 151,316 $0.9500 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests monthly in equal installments over three years commencing on July 5, 2025, subject to the Reporting Person's continued service through the applicable vesting date.